US equities
|
NVDA
$186.64
▲+2.78%
MU
$690.00
▲+5.12%
AMD
$449.04
▲+11.04%
SPCX
$134.27
▲+8.62%
AAPL
$342.37
▼-0.52%
SNDK
$835.06
▲+3.55%
MSFT
$530.61
▼-0.99%
TSLA
$358.22
▲+4.23%
NVDA
$186.64
▲+2.78%
MU
$690.00
▲+5.12%
AMD
$449.04
▲+11.04%
SPCX
$134.27
▲+8.62%
AAPL
$342.37
▼-0.52%
SNDK
$835.06
▲+3.55%
MSFT
$530.61
▼-0.99%
TSLA
$358.22
▲+4.23%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
NeOnc Technologies Holdings, Inc. - Common Stock
(NQ:
NTHI
)
3.490
+0.290 (+9.06%)
Delayed Quote
Updated: 4:00 PM EST, Nov 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about NeOnc Technologies Holdings, Inc. - Common Stock
< Previous
1
2
3
4
Next >
NeOnc CEO Accelerates Insider Buying with $500K+ Investment Ahead of Imminent NEO100 Phase 2a Data Catalysts
May 05, 2026
From
NeOnc Technologies Holdings, Inc.
Via
GlobeNewswire
New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Group Holding (NASDAQ:YYGH), and Vivos Therapeutics
April 18, 2026
Via
ACCESS Newswire
NeOnc Technologies Holdings, Inc. Announces ~ $300,000 in Insider Purchases of NTHI Stock by Chairman and CEO; Company Provides Context on 2025 Financial Results
April 14, 2026
From
NeOnc Technologies Holdings, Inc.
Via
GlobeNewswire
NeOnc Provides Business Update and Reports Q4 2025 Financial Results
April 01, 2026
From
NeOnc Technologies Holdings, Inc.
Via
GlobeNewswire
NeOnc Technologies Appoints David Choi as Chief Accounting Officer
March 13, 2026
From
NeOnc Technologies Holdings, Inc.
Via
GlobeNewswire
Stonegate Capital Partners Updates Coverage on NeOnc Technologies Holdings, Inc. (NTHI)
March 12, 2026
Dallas, Texas--(Newsfile Corp. - March 12, 2026) - NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI): Stonegate Capital Partners Updates Coverage on...
Via
Newsfile
NeOnc Technologies Reports Phase 1 Dose-Escalation Results for Dosing and Toxicity and Determination of Recommended Phase 2 Dose for Oral NEO212; Management to Host KOL Conference Call Today at 9 a.m. ET
March 04, 2026
From
NeOnc Technologies Holdings, Inc.
Via
GlobeNewswire
NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Dose-Escalation Results from Full Phase 1 NEO212-01 Readout for Dosing and Toxicity
February 27, 2026
From
NeOnc Technologies Holdings, Inc.
Via
GlobeNewswire
New to The Street to Broadcast Executive Leadership Interviews Tonight at 6:30 PM EST on Bloomberg Television Across the U.S., MENA and Latin America
February 21, 2026
Via
ACCESS Newswire
New to The Street to Broadcast Show #726 on Bloomberg at 6:30 PM EST Featuring Vivos Therapeutics (NASDAQ:VVOS), Aeries Technology (NASDAQ:AERT), Virtuix Holdings (NASDAQ:VTIX), and Stardust Power (NASDAQ:SDST)
February 14, 2026
Via
ACCESS Newswire
New to The Street(R) Airs Tonight on Bloomberg Television Across the U.S., MENA & Latin America
February 07, 2026
Via
ACCESS Newswire
New to The Street Broadcasts Today on Bloomberg Across the U.S., MENA, and Latin America
January 31, 2026
Via
ACCESS Newswire
NeOnc Technologies Secures Strategic PIPE Investment led by $10 Million Investment from Cinctive Capital Management
January 30, 2026
Investment led by Cinctive Co-Founder Richard Schimel underscores institutional confidence in NeOnc’s biotech pipeline
From
NeOnc Technologies Holdings, Inc.
Via
GlobeNewswire
Stonegate Capital Partners Initiates Coverage on NeOnc Technologies Holdings, Inc. (NTHI)
January 09, 2026
Dallas, Texas--(Newsfile Corp. - January 9, 2026) - NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI). Stonegate Capital Partners initiates their coverage...
Via
Newsfile
New to The Street Airs Tonight on Bloomberg Television - Show No. 712 Sponsored Programming Spotlighting Public and Private Market Innovators
January 03, 2026
Via
ACCESS Newswire
New to The Street Show #710 Airs Tonight at 6:30 PM EST on Bloomberg Television
December 27, 2025
Via
ACCESS Newswire
New to The Street Broadcasts Nationwide Tonight on Bloomberg Television Featuring NeOnc ($NTHI), Metaterra Holdings Inc., CISO Global ($CISO), and NRx Pharmaceuticals ($NRXP)
December 20, 2025
Via
ACCESS Newswire
NeOnc Technologies Reports Updated Clinical Results
December 15, 2025
Expanded Clinical Experience Demonstrates Additional Long-Term Survival and Radiographic Remission in Recurrent Grade III/IV IDH1-Mutant Astrocytoma Treated with Intranasal NEO100
From
NeOnc Technologies Holdings, Inc.
Via
GlobeNewswire
NeOnc Technologies (Nasdaq: NTHI) Announces AI-Driven Findings Showing Ultrasound Enhances the Potency of an Already Effective NEO100 in Treating Primary and Metastatic Brain Tumors
December 01, 2025
From
NeOnc Technologies Holdings, Inc.
Via
GlobeNewswire
NeOnc Technologies Holdings Reports Third Quarter 2025 Results and Provides Operational Update
November 14, 2025
From
NeOnc Technologies Holdings, Inc.
Via
GlobeNewswire
NeOnc Technologies Completes Enrollment in Pivotal NEO100 Phase2a Trial for IDH-1 mutant Recurrent High‑Grade Glioma and Expects Interim Data Readout in SixMonths (Q22026)
November 13, 2025
From
NeOnc Technologies Holdings, Inc.
Via
GlobeNewswire
NeOnc Technologies Reports Updated Clinical Results
November 12, 2025
Results of Clinical Trials Provide Evidence Supporting Significant Radiographic Response and Potential Long-Term Survival in Recurrent Grade III/IV IDH1-Mutant Astrocytoma Treated with Intranasal...
From
NeOnc Technologies Holdings, Inc.
Via
GlobeNewswire
NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program
November 07, 2025
From
NeOnc Technologies Holdings, Inc.
Via
GlobeNewswire
NeOnc Technologies Appoints Amir Heshmatpour as Chief Executive Officer to Drive Next Phase of Clinical and Corporate Growth
November 04, 2025
From
NeOnc Technologies Holdings, Inc.
Via
GlobeNewswire
His Highness Sheikh Nahyan bin Zayed Al Nahyan Assumes Executive Chairmanship of NeOnc Technologies' Subsidiary, NuroMENA, Pioneering UAE-US Partnership in Brain Cancer Treatment
October 28, 2025
From
NeOnc Technologies Holdings, Inc.
Via
GlobeNewswire
Meet the Companies - New to The Street's Accredited Investor Event Returns October 21-22 at Hudson Yards, NYC
October 10, 2025
Via
ACCESS Newswire
NeOnc Technologies' Subsidiary, NuroMENA, Signs Master Services Agreement with M42’s IROS and Expands Board of Directors
October 09, 2025
From
NeOnc Technologies Holdings, Inc.
Via
GlobeNewswire
New to The Street to Broadcast Tonight on Fox Business 10:30 PM PST Featuring NeOnc Technologies, FLOKI, XION, Sharps Technology, and Aeries Technology
October 06, 2025
Via
ACCESS Newswire
NeOnc Technologies and Quazar Investment Set to Close $50 Million Strategic Partnership by October 23rd Following Final UAE Tax Approvals
October 06, 2025
From
NeOnc Technologies Holdings, Inc.
Via
GlobeNewswire
NeOnc Technologies Appoints Dr. David M. Ashley, Director of The Preston Robert Tisch Brain Tumor Center at Duke, to Scientific Advisory Board
October 02, 2025
From
NeOnc Technologies Holdings, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
